What is actually established?
Three facts anchor the record, and none of them depends on speculation. First, the HHS Office for Civil Rights issued a bulletin on online tracking technologies, and a federal court later vacated that guidance in AHA v. Becerra - so the federal rulebook on hospital web tracking is, at the time of writing, unsettled. Second, the private litigation did not wait for the rulebook: Advocate Aurora Health settled pixel litigation for 12.225 million dollars, and class actions over hospital website tracking have continued regardless of the guidance question. Third, OCR and the FTC jointly sent roughly 130 warning letters to hospital systems and telehealth providers about tracking technologies on their websites and portals.
If the guidance was vacated, why does the risk remain?
Because the plaintiffs' theory does not rest on the vacated bulletin. The suits plead state privacy statutes, wiretap-style claims, breach of confidentiality, and consumer-protection theories - and their factual core is a network log: the complaint reproduces what the hospital's own pages transmitted to an advertising platform, page by page. A vacated federal bulletin does not change what the defendant's website sent, and the sending is the exposure.
The operational reading: the legal environment punishes not knowing. The organizations in the worst position are those that cannot say, with evidence, what their site transmits, to whom, and under what consent state - because they cannot assess their own exposure, cannot remediate precisely, and cannot answer a regulator's letter with anything but hope.
What did the affected organizations have in common?
The recurring pattern in the public record is not malice; it is drift. An advertising pixel installed for a legitimate campaign years earlier, still firing sitewide. A tag manager container with accumulated tags nobody currently owns. Appointment and portal pages built on the same templates as marketing pages, inheriting their tracking. And in the aftermath of the original guidance, many teams removed tools wholesale - and now cannot say with confidence what their site sends, because the removal was as unverified as the installation.
What should a marketing team do this quarter?
- Inventory at runtime. Load every page template with a real browser and record every outbound request, before and after consent interaction. This is evidence, not documentation of intent.
- Classify pages by sensitivity. Service lines, find-a-doctor, scheduling, portal entry, and symptom content are a different risk class from the newsroom. The tag set should differ accordingly, and provably.
- Assign an owner to every tag. A tag without a current owner and a current purpose is a liability with no offsetting benefit; remove it and verify the removal.
- Make the consent state testable. "The banner blocks it" is a hypothesis until someone rejects consent and reads the network log. Test both states on every sensitive template.
- Document the evidence trail. The deliverable that protects the organization is dated, reproducible, and written so that legal and privacy can read it without a translator.
Is removing all measurement the safe answer?
It is the expensive answer, and it is not even reliably safe - unverified removal leaves the same uncertainty as unverified installation. Hospitals still need to know whether service lines are found, whether campaigns produce appointment requests, and where digital experiences fail. The defensible position is measured measurement: minimal identifiers, sensitive paths handled deliberately, consent states verified, and the whole arrangement documented as evidence.